SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. LaMancha who wrote (76)12/17/1996 8:26:00 AM
From: Christopher Moylen   of 371
 
I have heard that Lehman Brothers will be putting an initial buy rating on IMMU sometime near the end of January/beginning of Feb. Just the mere fact that Lehman Brothers has taken the role of financial consultant and advisor to IMMU is promising. More importantly, Lehman Brothers does not work for free. They are major market makers in this country to many different companies. They make great deals of money by the upward movement in stocks they have an interest in or recommend.
This is no secret. Lehman Brothers has confidence in IMMU.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext